Active ingredientReboxetine MesylateCat. No. P-R024-001CAS 98769-84-7Family · Pharmaceutical analytical standards
Reboxetine
An antidepressant that selectively inhibits noradrenaline reuptake, discovered in Italy and first described in 1984: approved in Europe in 1997, it is used for major depression. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Its molecule has two chiral centres and therefore four possible stereoisomers: the medicine is a mixture of two of them, and the (S,S) form alone has been given its own name, esreboxetine.
Go to the active ingredient →Active ingredientReboxetine MesylateCat. No. P-R024-001CAS 98769-84-7
Isotopically labelled(S,S)-Reboxetine-d5Cat. No. P-R024-003
Isotopically labelledrac-Reboxetine-d5Cat. No. P-R024-004
Impurity(R, S)-ReboxetineCat. No. P-R024-005
Impurity(R,R)-ReboxetineCat. No. P-R024-006CAS 105017-38-7
Impurity(S, R)-ReboxetineCat. No. P-R024-007CAS 868686-70-8
Impurity(S,S)-ReboxetineCat. No. P-R024-008CAS 98819-76-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.